Patient Experience with PDTs

Patients who have used prescription digital therapeutics (PDTS) report high satisfaction with the convenience and accessibility these tools provide. Many patients appreciate having immediate access to therapeutic interventions when they need them, allowing them to work through difficult emotions and situations in their own space and time. This flexibility is particularly valuable for patients who experience symptoms outside of traditional therapy hours or those waiting months for therapy appointments.

Real-world patient experiences highlight the practical benefits of PDTs, with some patients noting that the cost of digital therapeutics may be comparable to that of therapy co-payments during extended waiting periods for traditional treatment. Patients frequently inquire about apps they discover through social media platforms, demonstrating their interest in digital mental health solutions. However, patients deserve access to evidence-based, FDA-approved digital therapeutics rather than unvalidated alternatives found in app stores.

The lack of comprehensive real-world evidence for PDTs primarily stems from accessibility issues rather than patient satisfaction or effectiveness concerns. Patients cannot provide meaningful feedback about treatments they cannot afford or access due to insurance coverage limitations. When patients do have access to PDTs, their positive experiences and satisfaction demonstrate the potential for these tools to become integral components of mental health care, provided that coverage barriers are addressed to ensure equitable access for all patients who could benefit.